This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

CalPERS Applauds CVS Caremark's Tobacco Exit

Stocks in this article: CVS

CalPERS' support of CVS decision did not cite any economic reasons and characterized its statement in the vein of what is important to the fund's constituents.

The fund, however, has a long tradition on putting its money behind social issues that also have an economic element. When divesting tobacco stocks in 2000, CalPERS cited the risk of prolonged litigation to its investment. The fund held over $500 million worth of tobacco stocks at the time.

In 2011, CalPERS said it would divest its holding of companies doing business in Iran and Sudan, causing the fund to sell shares in eight firms worth a total of $160 million. The fund and the California State Teachers Retirement System (CalSTRS) have also recently been pressed by students and California state employees to divest their holding of fossil fuel companies.

CalSTRS, another CVS shareholder, declined on Wednesday to discuss the company's decision to end tobacco sales. However, the fund eliminated new investments in tobacco in 2000 and divested its portfolio of all tobacco in 2009 on the basis of its negative impact on human health and how the nature of that impact affects the industry's long-term profitability.

That investment decision was characterized as part of the fund's fiduciary duty to its members.

Fiduciary Duty and Public Policy

In coming weeks and months, will be interesting to see whether CVS's cessation of tobacco sales will be seen as a compelling fiduciary decision or not. It may also prove yet another example of the tension between short-term and long-term shareholder interests.

If investors were unimpressed by the move, analysts covering CVS's stock appear to believe it could benefit the company in coming years.

"While we expect this change might be a near-term headwind, we believe it will help CVS differentiate itself from other large retail pharmacies and it may be an incremental benefit to the PBM's selling season," Leerink Swann analyst David Larsen  said in a Wednesday client note.

Bank of America Merrill Lynch called the tobacco decision a "smart strategy" and noted that tobacco sales were not important to the company's profitability. "We believe the clipped contribution pales in comparison to likely political and social gains to be had with a widespread media focus [on Wednesday]."

"Stopping the sale of cigarettes and tobacco will make a significant difference in reducing the chronic illnesses associated with tobacco use," Troyen A. Brennan, CVS Caremark Chief Medical Officer, said on Wednesday

The company also said its decision to stop selling tobacco products reflected positions taken by the American Medical Association, American Heart Association, American Cancer Society, American Lung Association and American Pharmacists Association.

2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,903.16 +98.36 0.55%
S&P 500 2,070.19 -0.46 -0.02%
NASDAQ 4,764.6990 -0.6810 -0.01%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs